High-Dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

OBJECTIVE: Use of high-dose cyclophosphamide without hematopoietic stem cell transplant (HSCT) to treat severe aplastic anemia (SAA) has been controversial due to concern for increased infectious toxicity as compared to anti thymocyte globulin (ATG) and cyclosporine (CSA). As children often tolerate...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Pediatr Hematol Oncol
Hoofdauteurs: Gamper, Christopher J., Takemoto, Clifford M., Chen, Allen R., Symons, Heather J., Loeb, David M., Casella, James F., Dezern, Amy E., King, Karen E., McGonigle, Andrea M., Jones, Richard J., Brodsky, Robert A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5074865/
https://ncbi.nlm.nih.gov/pubmed/27467367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000647
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items